Michael E. Maragoudakis

3.5k total citations
91 papers, 2.7k citations indexed

About

Michael E. Maragoudakis is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Michael E. Maragoudakis has authored 91 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 26 papers in Hematology and 24 papers in Cancer Research. Recurrent topics in Michael E. Maragoudakis's work include Blood Coagulation and Thrombosis Mechanisms (26 papers), Angiogenesis and VEGF in Cancer (22 papers) and Protease and Inhibitor Mechanisms (19 papers). Michael E. Maragoudakis is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (26 papers), Angiogenesis and VEGF in Cancer (22 papers) and Protease and Inhibitor Mechanisms (19 papers). Michael E. Maragoudakis collaborates with scholars based in Greece, United States and Switzerland. Michael E. Maragoudakis's co-authors include Nikos E. Tsopanoglou, Eva Pipili‐Synetos, Paraskevi Andriopoulou, George C. Haralabopoulos, Εvangelia Papadimitriou, George Karakiulakis, William W. Li, W. D. Thompson, Christodoulos Flordellis and D. S. Grant and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Michael E. Maragoudakis

91 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Maragoudakis Greece 30 1.3k 686 609 479 322 91 2.7k
Giovanna Balconi Italy 22 1.5k 1.1× 423 0.6× 318 0.5× 177 0.4× 275 0.9× 47 2.8k
John W. Forstrom United States 18 1.3k 1.0× 1.2k 1.7× 177 0.3× 177 0.4× 253 0.8× 23 3.5k
Kohji Hanasaki Japan 36 2.5k 1.9× 208 0.3× 301 0.5× 533 1.1× 208 0.6× 83 4.0k
Koichiro Mihara Canada 25 1.2k 0.9× 468 0.7× 313 0.5× 361 0.8× 321 1.0× 69 2.7k
Johan Sundelin Sweden 28 1.5k 1.1× 1.6k 2.3× 556 0.9× 165 0.3× 267 0.8× 39 3.5k
Ronald L. Heimark United States 32 2.4k 1.8× 437 0.6× 490 0.8× 198 0.4× 314 1.0× 61 4.1k
Irina Mikhailenko United States 31 1.3k 0.9× 409 0.6× 594 1.0× 436 0.9× 150 0.5× 45 3.0k
Giovanni Maria Garbarino Italy 28 855 0.6× 378 0.6× 177 0.3× 294 0.6× 171 0.5× 74 2.7k
Debra K. Newman United States 37 2.1k 1.6× 1.2k 1.8× 194 0.3× 323 0.7× 523 1.6× 109 4.5k
Nisar A. Pampori United States 21 928 0.7× 673 1.0× 246 0.4× 298 0.6× 187 0.6× 37 3.0k

Countries citing papers authored by Michael E. Maragoudakis

Since Specialization
Citations

This map shows the geographic impact of Michael E. Maragoudakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Maragoudakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Maragoudakis more than expected).

Fields of papers citing papers by Michael E. Maragoudakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Maragoudakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Maragoudakis. The network helps show where Michael E. Maragoudakis may publish in the future.

Co-authorship network of co-authors of Michael E. Maragoudakis

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Maragoudakis. A scholar is included among the top collaborators of Michael E. Maragoudakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Maragoudakis. Michael E. Maragoudakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsopanoglou, Nikos E. & Michael E. Maragoudakis. (2009). Thrombin's central role in angiogenesis and pathophysiological processes. European Cytokine Network. 20(4). 171–179. 28 indexed citations
2.
Aplin, Alfred C., et al.. (2008). Parstatin, the Cleaved Peptide on Proteinase-Activated Receptor 1 Activation, Is a Potent Inhibitor of Angiogenesis. Journal of Pharmacology and Experimental Therapeutics. 328(2). 378–389. 28 indexed citations
3.
Flordellis, Christodoulos, et al.. (2008). Thrombin mediates mitogenesis and survival of human endothelial cells through distinct mechanisms. American Journal of Physiology-Cell Physiology. 294(5). C1215–C1226. 21 indexed citations
4.
Tsopanoglou, Nikos E. & Michael E. Maragoudakis. (2004). Role of Thrombin in Angiogenesis and Tumor Progression. Seminars in Thrombosis and Hemostasis. 30(1). 63–69. 97 indexed citations
5.
Venema, Richard C., Virginia J. Venema, Hong Ju, et al.. (2003). Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. American Journal of Physiology-Heart and Circulatory Physiology. 285(2). H669–H678. 93 indexed citations
6.
Dimitropoulou, Christiana, Michael E. Maragoudakis, & Moritz A. Konerding. (2000). Effects of thrombin and of the phospholipase C inhibitor, D609, on the vascularity of the chick chorioallantoic membrane. General Pharmacology The Vascular System. 35(5). 241–247. 2 indexed citations
7.
Thompson, W. D., William W. Li, & Michael E. Maragoudakis. (1999). The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies. The Journal of Pathology. 187(5). 503–510. 66 indexed citations
8.
Tsopanoglou, Nikos E. & Michael E. Maragoudakis. (1999). On the Mechanism of Thrombin-induced Angiogenesis. Journal of Biological Chemistry. 274(34). 23969–23976. 181 indexed citations
9.
Malkusch, W, et al.. (1998). The vascular architecture of the chick chorioallantoic membrane: sequential quantitative evaluation using corrosion casting. Angiogenesis. 2(3). 255–263. 26 indexed citations
10.
Maragoudakis, Michael E., Pietro M. Gullino, & Peter I. Lelkes. (1994). Angiogenesis : molecular biology, clinical aspects. Plenum Press eBooks. 11 indexed citations
11.
Maragoudakis, Michael E., et al.. (1994). Inhibition of Angiogenesis by Anthracyclines and Titanocene Dichloridea. Annals of the New York Academy of Sciences. 732(1). 280–293. 41 indexed citations
12.
Pipili‐Synetos, Eva, et al.. (1994). Leukotrienes C4 and D4 promote angiogenesis via a receptor-mediated interaction. European Journal of Pharmacology. 258(1-2). 151–154. 38 indexed citations
13.
Pipili‐Synetos, Eva, et al.. (1994). Evidence that nitric oxide is an endogenous antiangiogenic mediator. British Journal of Pharmacology. 111(3). 894–902. 141 indexed citations
14.
Pipili‐Synetos, Eva, et al.. (1993). Protein Kinase C Involvement in the Regulation of Angiogenesis. Journal of Vascular Research. 30(4). 202–208. 34 indexed citations
15.
Maragoudakis, Michael E., et al.. (1990). Basement membrane biosynthesis as a target to tumor therapy.. Journal of Pharmacology and Experimental Therapeutics. 252(2). 753–757. 13 indexed citations
16.
Pipili‐Synetos, Eva, et al.. (1990). Endothelium removal does not abolish angiotensin converting enzyme activity from the mesenteric arterial bed of the rat. Biochemical Pharmacology. 40(5). 1149–1151. 13 indexed citations
17.
Karakiulakis, George, et al.. (1990). Antitumor effect of GPA1734 in rat Walker 256 carcinoma. Investigational New Drugs. 8(2). 145–147. 8 indexed citations
18.
Karakiulakis, George, et al.. (1990). Basement membrane collagen-degrading activity from a malignant tumor is inhibited by anthracycline antibiotics. Biochimica et Biophysica Acta (BBA) - General Subjects. 1035(2). 218–222. 14 indexed citations
19.
Manolopoulos, Vangelis G., et al.. (1989). Angiotensin converting enzyme activity is present in the endothelium‐denuded aorta. British Journal of Pharmacology. 98(2). 333–335. 27 indexed citations
20.
Maragoudakis, Michael E., Helen Kalinsky, & James Wasvary. (1978). Effects of L-dopa, GPA 1734 and other agents on basement membrane biosynthesis.. Journal of Pharmacology and Experimental Therapeutics. 204(2). 372–383. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanna Balconi Breakdown of academic impact, for papers by John W. Forstrom Breakdown of academic impact, for papers by Kohji Hanasaki Breakdown of academic impact, for papers by Koichiro Mihara Breakdown of academic impact, for papers by Johan Sundelin Breakdown of academic impact, for papers by Ronald L. Heimark Breakdown of academic impact, for papers by Irina Mikhailenko Breakdown of academic impact, for papers by Giovanni Maria Garbarino Breakdown of academic impact, for papers by Debra K. Newman Breakdown of academic impact, for papers by Nisar A. Pampori
Rankless by CCL
2026